Beijing chao-yang Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Location status: Recruiting
NCT Number: NCT06575101
This study is a single-center, prospective, observational study. According to the sample size formula, an estimated 40 cases should be collected, all of whom are from the emergency intensive care unit. After successful cardiopulmonary resuscitation, the enrolled patients will be transferred to the emergency intensive care unit for further standardized target temperature management (TTM). They will be divided into 33 ° C hypothermia group and 36 ° C hypothermia group according to the patient's core body temperature. The baseline data of the patients will be collected at the beginning. After admission to the hospital, they were fasted within 24 hours to reach the target temperature, and then 20kcal/kg/d parenteral nutrition will be given. At selected time points (T0: the initial time point before TTM; T1: the core temperature was reduced to 33 ° C or 36 ° C; T2-T4: 33 ° C or 36 ° C was maintained for 24h, 48h, 72h; T5: the end of rewarming; Tend: the last REE measurement before discharge or death) , various observation indicators will be collected, including resting energy expenditure (REE), glucose oxidation rate, fat oxidation rate, protein oxidation rate, and metabolism of three major nutrients Proportion. Neurological outcomes were followed up 28 days after onset according to the Cerebral Performance Categories (CPC) score.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Beijing, Beijing Municipality, China
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Target Temperature Management Treatment
Time frame: 7 days
The primary outcome measure is the changes resting energy expenditure(REE) in the patients at various time points.
patients at various time points.
Time frame: 7 days
The primary outcome measure is the statistical differences in Glucose oxidation rate between the two groups of patients at various time points.
Time frame: 7 days
The primary outcome measure is the statistical differences in fat oxidation rate between the two groups of patients at various time points.
Time frame: 7 days
The primary outcome measure is the statistical differences in protein oxidation rate between the two groups of patients at various time points.
Time frame: 7 days
The primary outcome measure is the statistical differences in metabolic supply proportion of glucose, fat, protein (measuring by indirect calorimetry) between the two groups of patients at various time points.
Time frame: 28 days
CPC = Cerebral Performance Category Score.There are 5 levels of CPC score. CPC 1-2 means good prognosis of neurological function, CPC3-5 means bad prognosis of neurological function. The Secondary Outcome of the study is the statistical differences in the proportion of patients with good neurological outcome(CPC1-2) in the two groups at 28 days after CA.
Time frame: 28 days
The Secondary Outcome of the study is the statistical differences in the mortality rate of two groups at 28 days after CA.
Contact information is provided by the study sponsor or research team.
Tang Ziren
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07239206
Cardiac Arrest, Cardiovascular Diseases
Taipei, Taiwan
View Trial DetailsNCT06543849
Cardiac Arrest, Cardiovascular Diseases
Beijing, Beijing Municipality, China
View Trial DetailsNCT06256354
Cancer Surgery, Confusion
Chizhou, Anhui, China
View Trial DetailsNCT07302009
Brain Diseases, Cardiovascular Diseases
Nanchang, Jiangxi, China
View Trial Details